Pediatric ocular motor cranial nerve palsy: Demographics and etiological profile

Capecitabine and sixth cranial nerve palsy.

Capecitabine is an oral chemotherapeutic agent converted to 5 fluorouracil (5-FU). Neurotoxicity associated with the medication encompasses both central and peripheral nervous systems. We describe a 60 year old man with colonic carcinoma who developed diplopia due to a sixth nerve palsy following the use of capecitabine which is an orally administered prodrug of 5-FU. An MRI of brain did not re...

Cranial nerve palsy following retrobulbar anaesthesia.

Management of congenital fourth cranial nerve palsy.

Nasal cause of sixth cranial nerve palsy.

Anatomically the cavernous sinus is closely related to the sphenoid sinus and the nasopharynx. Sphenoid sinusitis, as demonstrated in the case can affect the nerves which are contained within it. Apart from the sinus, a direct extension from a nasopharyngeal lesion is commonly encountered to cause diplopia, owing to the sixth nerve involvement. The provisional diagnosis should be a nasopharynge...

Diplopia due to ocular motor cranial neuropathies.

PURPOSE OF REVIEW Determining which cranial nerve(s) is (are) involved is a critical step in appropriately evaluating a patient with diplopia. RECENT FINDINGS New studies have looked at the various etiologies of cranial nerve palsies in the modern imaging era. The importance of the C-reactive protein test in evaluating the possibility of giant cell arteritis has recently been emphasized. SU...